• vcard
  • Education
    • J.D., cum laude, Boston University School of Law, 2018
    • B.A., cum laude, College of the Holy Cross, 2013

Danny provides legal advice to emerging growth companies in a variety of stages of the business life cycle. His practice focuses on advising companies on a wide array of corporate matters, including formation, financing, mergers and acquisitions and general corporate governance matters. Danny helps the legal and business teams to anticipate and address challenges that a growing company encounters and identify available options to help ensure the client’s business is on the most successful path.

  • Represented Gencove Inc., a leading low-pass genome sequencing platform company in a $10 million Series A financing.
  • Represented Cemvita Factory, an industrial biotechnology company focusing on reversing climate change, on its Series A financing.
  • Represented MDaaS Global Corp. a healthtech company building and operating a network of modern, tech-enabled diagnostic centers across Nigeria, in its $2.3 million financing.
  • Represented Wagmo, Inc. a pet insurance and wellness company, on its $12.5 million Series A financing.
  • Represented biotechnology company in its $1.7 billion acquisition of gene therapy manufacturing company.
  • Represented Obsess, Inc. a leading experimental virtual reality retail platform that enables brands to create interactive, shoppable online virtual stores and showrooms in a $3.4 million Series Seed Financing. 
  • Represented Tive, Inc. a leading global supply chain visibility provider, in its $12 million Series A financing.
  • Represented Dive Technologies, Inc. a Boston-based subsea robotics designer and manufacturer, in a new round of preferred stock financing totaling $4 million.
Related News